Pubblicazioni

Daratumumab, bortezomib, and dexamethasone for multiple myeloma

2016 - NEW ENGLAND JOURNAL OF MEDICINE

Palumbo, Antonio; Chanan Khan, Asher; Weisel, Katja; Nooka, Ajay K.; Masszi, Tamas; Beksac, Meral; Spicka, Ivan; Hungria, Vania; Munder, Markus; Mateos, Maria V.; Mark, Tomer M.; Qi, Ming; Schecter, Jordan; Amin, Himal; Qin, Xiang; Deraedt, William; Ahmadi, Tahamtan; Spencer, Andrew; Sonneveld, Pieter; Foa, Roberto; Castor, Investigators

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib

2015 - BIOCHEMICAL PHARMACOLOGY

Graziani, Grazia; Artuso, Simona; De Luca, Anastasia; Muzi, Alessia; Rotili, Dante; Scimeca, Manuel; Atzori, Maria Grazia; Ceci, Claudia; Mai, Antonello; Leonetti, Carlo; Levati, Lauretta; Bonanno, Elena; Tentori, Lucio; Caccuri, Anna Maria

Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group

2015 - HAEMATOLOGICA

D'AngiÃ², M; Valsecchi, Mg; Testi, Anna Maria; Conter, V; Nunes, Vittorio; Parasole, R; Colombini, A; Santoro, N; Varotto, S; Caniglia, M; Silvestri, D; Consarino, C; Levati, L; Magrin, E; Locatelli, F; Basso, G; Foa, Roberto; Biondi, A; Cazzaniga, G.

An overview of early investigational therapies for chemoresistant ovarian cancer

2015 - EXPERT OPINION ON INVESTIGATIONAL DRUGS

Marchetti, Claudia; Ledermann, Jonathan A.; BENEDETTI PANICI, Pierluigi